Reduce the risk of sustained eGFR decline, End Stage Kidney Disease, Cardiovascular death, Non-fatal myocardial infarction, and hospitalization for Heart failure in adult patients with Chronic Kidney Disease, (CKD) associated with Type 2 Diabetes (T2D), Diabetic Kidney Disease